February 11, 2020 / 11:50 AM / 8 days ago

BRIEF-Fennec Pharmaceuticals Completes Rolling Submission Of NDA To U.S. FDA For Pedmark

Feb 11 (Reuters) - Fennec Pharmaceuticals Inc:

* FENNEC PHARMACEUTICALS COMPLETES ROLLING SUBMISSION OF NEW DRUG APPLICATION (NDA) TO U.S. FOOD AND DRUG ADMINISTRATION FOR PEDMARK™ AND ALSO SUBMITS MARKETING AUTHORIZATION APPLICATION (MAA) TO EUROPEAN MEDICINES AGENCY

* FENNEC PHARMACEUTICALS - IF PEDMARK IS GRANTED A PRIORITY REVIEW, PDUFA DATE IS EXPECTED IN Q3 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below